Elif Erkan, MD, MS
- Pediatric Nephrologist, Division of Nephrology
- Professor, UC Department of Pediatrics
- elif.erkan@cchmc.org
- Board Certified
About
Biography
I received the prestigious SPR Fellow's Basic Research Award upon completing my pediatric nephrology fellowship. I pursued a career as a physician scientist and continued to investigate the mechanism of proteinuria-induced injury in proximal tubule cells following my fellowship. My laboratory demonstrated an important link between the endocytic adapter protein disabled-2 (Dab2), which binds to the cytoplasmic tail of the albumin receptor megalin, and protein kinase B (Akt). I received an NIH career development-KO8 award to support my studies elucidating the link between albumin endocytosis and cell signaling events.
MD: Ankara University School of Medicine, Ankara, Turkey, 1990
Residency: Pediatrics, Marmara University Hospital, Istanbul, Turkey, 1997
Residency: Pediatrics, Montefiore Medical Center, Albert Einstein School of Medicine, Bronx, NY, 2002
Fellowship: Pediatric Nephrology, Montefiore Medical Center, Albert Einstein School of Medicine, Bronx, NY, 2000
MS: Clinical Research Methods, Montefiore Medical Center, Albert Einstein School of Medicine, Bronx, NY, 2001
Interests
Proteinuria; nephrotic syndrome.
Services and Specialties
Interests
Proteinuria induced tubular injury; tubular apoptosis; albumin endocytosis.
Research Areas
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
Individualised treatment effects of corticosteroids in IgA nephropathy. EBioMedicine. 2026; 130:106396.
A Pilot Study of Urinary Cubilin Shedding in Type 1 Diabetes Mellitus: A Potential Biomarker to Predict Nephropathy. Journal of Diabetes Research. 2026; 2026(1):e2291735.
Downregulation of Akt induces proximal tubule epithelial cell apoptosis via FOXO and BIM pathway in proteinuric States. Scientific Reports. 2025; 15(1):37661.
Circulating Lipid Metabolites Exacerbate Progression via Podocyte Injury in FSGS. Journal of the American Society of Nephrology. 2025; 36(10S):10.1681/asn.2025hymvc5sn.
Defining subgroups of pediatric nephrotic patients with urine proteomics. Scientific Reports. 2025; 15(1):25064.
Clinical Significance of Immune Deposits and Complement System Activation in FSGS: Findings from the Cure Glomerulonephropathy Network Study. Kidney360. 2025; 6(8):1384-1393.
Family History in the Context of CKD. Journal of the American Society of Nephrology. 2025; 36(8):1561-1571.
ALONE WE SURVIVE, TOGETHER WE THRIVE: INTERNATIONAL MEDICAL GRADUATE EMPOWERMENT INITIATIVE. Academic Pediatrics. 2025; 25(1):102690.
Responding to the workforce crisis: consensus recommendations from the Second Workforce Summit of the American Society of Pediatric Nephrology. Pediatric Nephrology. 2024; 39(12):3609-3619.
Urinary Lipid Biomarkers Predict Progression in Focal Segmental Glomerulosclerosis. Journal of the American Society of Nephrology. 2024; 35(10S):10.1681/asn.2024dckvfdtw.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 2026 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey